FDA 21 CFR 177.2600

Realizing that contamination risks made 70% of recalls in the biopharma industry, was one of the most shocking statistics I had ever come across. This fact helped me comprehend how critical sterility is for biopharmaceutical applications, which in turn motivated me to explore ways that could help avoid such financially damaging obstacles. It was at …